Show simple item record

dc.contributor.authorWang, Youjin
dc.contributor.authorBest, Ana
dc.contributor.authorFernández Torrón, Roberto
dc.contributor.authorAlsaggaf, Rotana
dc.contributor.authorGarcía Puga, Mikel
dc.contributor.authorDagnall, Casey L.
dc.contributor.authorHicks, Belynda
dc.contributor.authorThompson, Mone’t
dc.contributor.authorMatheu Fernández, Ander
dc.contributor.authorZulaica Ijurco, Miren
dc.contributor.authorGreene, Mark H.
dc.contributor.authorLópez de Munain Arregui, Adolfo José
dc.contributor.authorGadalla, Shahinaz M.
dc.date.accessioned2020-03-12T09:46:35Z
dc.date.available2020-03-12T09:46:35Z
dc.date.issued2019-12
dc.identifier.citationAnnals of Clinical and Translational Neurology 7(1) : 126-131 (2019)es_ES
dc.identifier.issn2328-9503
dc.identifier.urihttp://hdl.handle.net/10810/42159
dc.description.abstractMyotonic dystrophy type I (DM1) is an autosomal dominant disease of which clinical manifestations resemble premature aging. We evaluated the contribution of telomere length in pathogenesis in 361 DM1 patients (12 with serial measurements) and 223 unaffected relative controls using qPCR assay. While no differences in baseline leukocyte relative telomere length (RTL) was noted, the data suggested an accelerated RTL attrition in DM1 (discovery cohort: T/S change/year = -0.013 in DM1 vs. -0.005 in controls, P = 0.04); similar trend was noted in validation cohort. Further investigations are needed to examine the role of TL in the pathophysiology of DM1.es_ES
dc.description.sponsorshipThe study was supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health.es_ES
dc.language.isoenges_ES
dc.publisherWileyes_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subjectoxidative stresses_ES
dc.subjectcancer-riskes_ES
dc.subjectctg repeates_ES
dc.subjectagees_ES
dc.titleLeukocyte telomere length in patients with myotonic dystrophy type I: a pilot studyes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.holder2019 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.es_ES
dc.rights.holderAtribución 3.0 España*
dc.relation.publisherversionhttps://onlinelibrary.wiley.com/doi/full/10.1002/acn3.50954es_ES
dc.identifier.doi10.1002/acn3.50954
dc.departamentoesNeurocienciases_ES
dc.departamentoeuNeurozientziakes_ES


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

2019 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Except where otherwise noted, this item's license is described as 2019 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.